European Leukemia Trial Registry
Trial: CMPE Treosulfan + PBPCT in OMF

More Details
Scientific Title Myeloablative conditioning of patients with myelofibrosis with myeloid metaplasia (MMM) using i.v. Treosulfan and autologous peripheral blood progenitor cell transplantation (PBPCT) with high doses of CD34+ cells
Short Title CMPE Treosulfan + PBPCT in OMF
Trialgroup CMPE-Expertengruppe
Type of Trial multicentric
Disease Myeloproliferative disease(MPD) Myelofibrosis
Age >= 18 years
Status Closed
Start of Recruitment 09.06.2003
Leader Frühauf, PD Dr. med., Stefan
Contactperson

Study Physician
Buss, Dr. med., Eike
Tel: +49 (0)6221 56 2781
Fax: +49 (0)6221 56 5722

Study Centre
Opgenorth, Annette
Tel: +49 (0)6221 568006
Fax: +49 (0)6221 565791
Email: annette.opgenorth@med.uni-heidelberg.de

Study Centre
Geueke, A.-M.
Tel: +49 (0)6221 568006
Fax: +49 (0)6221 565791
Email: haem-onk_studien@med.uni-frankfurt.de

Biometrics
Benner, A.
Tel: +49 (0)6221 422390
Fax: +49 (0)6221 422397
Email: benner@dkfz-heidelber.de
Homepage: www.dkfz.de

Centre of Trial Universitätsklinikum Heidelberg
Shortprotocol Shortprotocol
Diagnostics

Cytogenetics
Institut für Humangenetik, Universität Heidelberg

Histology
Pathologisches Institut der Universität Hannover

created 07.07.2006 Anja Hellenbrecht
changed 20.03.2015 Hanna Ebert
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org